Efficacy of Single-Dose Del Nido Cardioplegia Beyond 90 Minutes in Adult Cardiac Surgery
- PMID: 40217698
- PMCID: PMC11989696
- DOI: 10.3390/jcm14072248
Efficacy of Single-Dose Del Nido Cardioplegia Beyond 90 Minutes in Adult Cardiac Surgery
Abstract
Background: Del Nido (DN) cardioplegia is widely used in cardiac surgery for its efficacy in providing myocardial protection for up to 90 min with a single dose. However, its safety and efficacy during prolonged ischemia remain unclear. Methods: This retrospective study analyzed 471 patients who underwent cardiac surgery with CPB between January 2019 and September 2024. Patients were divided into two groups: ACC durations of 60-90 min (Group A, n = 240) and >90 min (Group B, n = 231). The perioperative characteristics, clinical outcomes, and biochemical markers were compared to evaluate the impact of prolonged ischemia. Results: Patients in Group B exhibited significantly higher postoperative troponin I and lactate levels at 4 h post-CPB, suggesting increased myocardial and metabolic stress. Lactate levels normalized within 24 h, indicating transient myocardial dysfunction. Defibrillation requirements and vasoactive inotropic score (VIS) were also significantly elevated in Group B, reflecting compromised myocardial electrical stability and hemodynamic challenges. However, the long-term outcomes such as mortality, LCOS, and MODS showed no significant differences between the groups. Conclusions: While DN cardioplegia provides sufficient myocardial protection for ACC durations within 90 min, its efficacy diminishes during prolonged ischemia, as evidenced by increased myocardial injury and hemodynamic instability. Tailored strategies, including standardized redosing protocols and enhanced perioperative management, are essential for optimizing outcomes in complex surgeries with extended ischemia times. Further prospective studies are needed to refine these protocols and assess alternative solutions for myocardial protection.
Keywords: cardioplegia; del Nido cardioplegia; ischemia–reperfusion injury; myocardial protection.
Conflict of interest statement
The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.
Figures




Similar articles
-
Traditional vs. modified Ringer lactate-based del Nido cardioplegia impacts on clinical outcomes in patients undergoing coronary artery bypass grafting: Results from a prospective, randomized, blinded trial.J Extra Corpor Technol. 2024 Dec;56(4):159-166. doi: 10.1051/ject/2024010. Epub 2024 Sep 20. J Extra Corpor Technol. 2024. PMID: 39718017 Free PMC article. Clinical Trial.
-
The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery.Heart Surg Forum. 2021 Jan 15;24(1):E038-E047. doi: 10.1532/hsf.3265. Heart Surg Forum. 2021. PMID: 33635267
-
Clinical impact of del Nido cardioplegia in adult cardiac surgery: A prospective randomized trial.J Thorac Cardiovasc Surg. 2023 Nov;166(5):1458-1467. doi: 10.1016/j.jtcvs.2022.01.044. Epub 2022 Feb 8. J Thorac Cardiovasc Surg. 2023. PMID: 35279289 Clinical Trial.
-
Del Nido cardioplegia in adult cardiac surgery: A narrative review.Perfusion. 2025 May 9:2676591251340970. doi: 10.1177/02676591251340970. Online ahead of print. Perfusion. 2025. PMID: 40340554 Review.
-
Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia.J Clin Med. 2024 Nov 19;13(22):6977. doi: 10.3390/jcm13226977. J Clin Med. 2024. PMID: 39598121 Free PMC article. Review.
References
-
- Yerebakan H., Sorabella R.A., Najjar M., Castillero E., Mongero L., Beck J., Hossain M., Takayama H., Williams M.R., Naka Y., et al. Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: A propensity matched comparison. J. Cardiothorac. Surg. 2014;9:141. - PMC - PubMed
-
- Ad N. Del Nido cardioplegia: Ready for prime time in adult cardiac surgery? J. Thorac. Cardiovasc. Surg. 2015;149:637–638. - PubMed
LinkOut - more resources
Full Text Sources